Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2351)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (101)
  6. Guidelines (40)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4749)
  2. Department of Medicine (4747)
  3. Center for Pancreatic Cancer Research (2316)
  4. Surgery (1067)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (843)

More Groups

People
  1. Eileen O'Reilly (804)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (224)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (322)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4749)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aspirin is associated with improved liver function after embolization of hepatocellular carcinoma
    Journal Article

    Boas, F. E.; Brown, K. T.; Ziv, E.; Yarmohammadi, H.; Sofocleous, C. T.; Erinjeri, J. P.; Harding, J. J.; Solomon, S. B.
    American Journal of Roentgenology (2019)

    Fulltext@MSK | Save
  • Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial
    Meeting Abstract

    Javle, M.; Borbath, I.; Clarke, S.; Hitre, E.; Louvet, C.; Macarulla, T.; Oh, D.; Spratlin, J.; Valle, J.; Weiss, K.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • ANCHOR CRC: A phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BIM), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Grothey, A.; Yaeger, R.; Paez, D.; Tabernero, J.; Taïeb, J.; Yoshino, T.; Groc, M.; Vedovato, J.; Chetaille, E.; Van Cutsem, E.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellulat carcinoma (HCC)
    Meeting Abstract

    Miksad, R.; Cicin, I.; Chen, Y.; Klumpen, H.; Kim, S.; Lin, Z.; Youkstetter, J.; Sen, S.; Cheng, A.; Meyer, T.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: A double-blind, randomized, placebo-controlled phase 3 study
    Meeting Abstract

    Chung, H.; Bang, Y.; Fuchs, C.; Qin, S.; Satoh, T.; Shitara, K.; Tabernero, J.; Van Cutsem, E.; Cao, Z.; Chen, X.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Analysis of patient screening in the phase III, international, randomized, open-label APACT trial
    Meeting Abstract

    Reni, M.; Winter, J.; Tortora, G.; Pelzer, U.; Riess, H.; Chang, H.; O'Reilly, E.; Oh, D.; Diaz, I. A.; Milella, M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): Primary analysis and quality of life outcomes
    Meeting Abstract

    Reni, M.; Riess, H.; O'Reilly, E.; Santoro, A.; Park, J.; Bekaii-Saab, T.; Tempero, M.; Shan, Y.; Macarulla, T.; Van Cutsem, E.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Comparative analyses between younger and older patients with pancreatic adenocarcinoma: Differences in clinicopathological features, treatment patterns, and outcomes
    Meeting Abstract

    Salem, M.; Kadakia, K.; Trufan, S.; Hwang, J.; Nazemzadeh, R.; Jagosky, M.; Worrilow, W.; Coley, H.; Al Hallak, M.; Gower, N.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: Phase III POLO trial
    Meeting Abstract

    Golan, T.; Hammel, P.; Reni, M.; Van Cutsen, E.; Macarulla, T.; Hall, M.; Park, J.; Hochhauser, D.; Arnold, D.; Oh, D.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Treating HER2-mutant advanced biliary tract cancer with neratinib: Benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket; trial
    Meeting Abstract

    Harding, J.; Cleary, J.; Shapiro, G.; Braña, I.; Moreno, V.; Quinn, D.; Borad, M.; Loi, S.; Spanggaard, I.; Stemmer, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save